ZEB1 associates with poorer survival in most carcinomas, including CRCs (13, 15, 16, 29,34, 35); however, the role of ZEB1 in BRAF-mutant CRCs or a potential differential role of ZEB1 in CRCs based on the mutational status have not been explored. The gene discussed is BRAF; the disease is carcinoma.